FIELD: medicine.
SUBSTANCE: invention refers to experimental biology and medicine and concerns a method for stimulating production of granulocyte colony-stimulating factor in vitro. Substance of the method: CD11b+Ly-6G- bone marrow cells are cultured in CO2 incubator at 37 °C, 5 % CO2 and 100 % air humidity for 24 hours in a culture medium, containing 90 % RPMI-1640, 10 % ETS, 280 mg/l L-glutamine, 50 mg/l gentamycin and C-Jun N-terminal kinase (JNK) inhibitor in effective concentration. Use of the invention provides higher efficiency of the method.
EFFECT: proposed method enables to effectively stimulate production of granulocyte colony-stimulating factor by bone marrow cells in vitro.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2020 |
|
RU2741784C1 |
METHOD FOR STIMULATING GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2017 |
|
RU2665818C1 |
METHOD FOR STIMULATION OF ERYTHROPOIETIN PRODUCTION BY BONE MARROW CELLS IN VITRO | 2019 |
|
RU2713122C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOETIN BY BONE MARROW CELLS IN VITRO | 2016 |
|
RU2628882C1 |
METHOD OF STIMULATION IN VITRO PLURIPOTENT HEMOPOETIC STEM CELLS | 2010 |
|
RU2439147C1 |
HEMOSTIMULATING AGENT | 2017 |
|
RU2647833C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOIETIN IN A CELL CULTURE in vitro | 2015 |
|
RU2589288C1 |
AGENT STIMULATING MESENCHYMAL PROGENITOR CELL FUNCTIONS IN VITRO | 2018 |
|
RU2686718C1 |
HEMOPROTECTIVE AGENT | 2019 |
|
RU2725135C1 |
VENLAFAXINE METABOLISM INDUCER | 2021 |
|
RU2777409C1 |
Authors
Dates
2022-04-21—Published
2021-03-24—Filed